Ensysce Biosciences's market cap is currently $7.35M. The company's EPS TTM is $-27.261; its P/E ratio is ―; Ensysce Biosciences is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is $-2.73. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 2.23M	$ 2.52M	$ 3.53M	$ 3.93M	$ 1.76M
Gross Profit	$ -5.36M	$ -17.31M	$ 3.53M	$ 2.56M	$ -1.56M
Operating Income	$ -10.72M	$ -24.22M	$ -19.87M	$ -1.61M	$ -3.33M
EBITDA	$ -10.72M	$ -24.22M	$ -19.87M	$ -1.61M	$ 921.15K
Net Income	$ -10.61M	$ -24.96M	$ -29.15M	$ -938.73K	$ 1.48M
Balance Sheet
Cash & Short-Term Investments	$ 1.12M	$ 3.15M	$ 12.26M	$ 194.21K	$ 1.06M
Total Assets	$ 2.71M	$ 5.89M	$ 16.42M	$ 351.81K	$ 196.51M
Total Debt	$ 854.70K	$ 4.41M	$ 12.75M	$ 4.27M	$ 566.27K
Net Debt	$ -268.91K	$ 1.26M	$ 483.42K	$ 4.08M	$ -494.88K
Total Liabilities	$ 3.36M	$ 9.91M	$ 24.58M	$ 7.01M	$ 10.34M
Stockholders' Equity	$ -322.86K	$ -4.03M	$ -8.16M	$ -6.44M	$ 186.17M
Cash Flow
Free Cash Flow	$ -10.78M	$ -17.89M	$ -8.24M	$ -1.25M	$ 10.99M
Operating Cash Flow	$ -10.78M	$ -17.89M	$ -8.24M	$ -1.25M	$ 10.99M
Investing Cash Flow	$ 0.00	$ 4.50K	$ 0.00	$ 183.40M	$ -566.29K
Financing Cash Flow	$ 8.76M	$ 8.77M	$ 20.31M	$ 1.10M	$ -11.03M

Currency in USD

Ensysce Biosciences Earnings and Revenue History

Income Statement >

Ensysce Biosciences Debt to Assets

Balance Sheet >

Ensysce Biosciences Cash Flow

Cash Flow >

Ensysce Biosciences Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing